The research group of Prof. Masaru Ishii (Immunology and Cell Biology, IFReC/Graduate School of Medicine, Osaka University) identified the molecular mechanism by which HSPCs (hematopoietic stem and progenitor cells) recover after injury.

Figure 1. Schematic of a novel mechanism of hematopoietic recovery. After chemotherapy, bone marrow-resident group 2 innate lymphoid cells (ILC2s) receive cytokine signals from dying cells and support hematopoietic recovery through secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF). (credit: Osaka University)

Commentary（PDF)

Article​(External Link）

Contact:

Masaru Ishii Lab.

06-6879-3881
mishiiicb.med.osaka-u.ac.jp